18 results
8-K
EX-3.2
TNFA
TNF Pharmaceuticals Inc.
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm
independent director from among its members. The chairperson of the board, at least until July 21, 2024, shall be required to be rotated among … the effect of removing any director before that director’s term of office expires. In addition to a chairperson, the board of directors may elect a lead
8-K
EX-3.3
owtam
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
425
04k12
19 Nov 20
Business combination disclosure
8:48am
8-K
EX-3.1
m0k3qqqzy9s6
27 Jul 20
Departure of Directors or Certain Officers
12:00am
8-K
dq6m bzhj
19 Oct 18
Departure of Directors or Certain Officers
8:45am
8-K
EX-3.1
bg4 1wzsap8ar0n3l
19 Oct 18
Departure of Directors or Certain Officers
8:45am
- Prev
- 1
- Next